Back to
KEYBANK NATIONAL ASSOCIATION/OH
VKTX
Showing 0 of 4 quarters
Position history for
KEYBANK NATIONAL ASSOCIATION/OH's holdings in VIKING THERAPEUTICS INC
No. KeyBank exited its VKTX (Viking Therapeutics) position in Q3 2022. Its Q2 2022 13F listed 28,000 shares worth $81,000. KeyBank first reported VKTX in Q4 2021 and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.